292 related articles for article (PubMed ID: 19815822)
1. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice.
Liu Q; Sargent MA; York AJ; Molkentin JD
Circ Res; 2009 Nov; 105(11):1110-7. PubMed ID: 19815822
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.
Liu Q; Wilkins BJ; Lee YJ; Ichijo H; Molkentin JD
Mol Cell Biol; 2006 May; 26(10):3785-97. PubMed ID: 16648474
[TBL] [Abstract][Full Text] [Related]
3. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
5. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
[TBL] [Abstract][Full Text] [Related]
6. Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.
Meijles DN; Cull JJ; Markou T; Cooper STE; Haines ZHR; Fuller SJ; O'Gara P; Sheppard MN; Harding SE; Sugden PH; Clerk A
Hypertension; 2020 Oct; 76(4):1208-1218. PubMed ID: 32903101
[TBL] [Abstract][Full Text] [Related]
7. The IP3 receptor regulates cardiac hypertrophy in response to select stimuli.
Nakayama H; Bodi I; Maillet M; DeSantiago J; Domeier TL; Mikoshiba K; Lorenz JN; Blatter LA; Bers DM; Molkentin JD
Circ Res; 2010 Sep; 107(5):659-66. PubMed ID: 20616315
[TBL] [Abstract][Full Text] [Related]
8. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy.
Taniike M; Yamaguchi O; Tsujimoto I; Hikoso S; Takeda T; Nakai A; Omiya S; Mizote I; Nakano Y; Higuchi Y; Matsumura Y; Nishida K; Ichijo H; Hori M; Otsu K
Circulation; 2008 Jan; 117(4):545-52. PubMed ID: 18195174
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.
Wu QQ; Xu M; Yuan Y; Li FF; Yang Z; Liu Y; Zhou MQ; Bian ZY; Deng W; Gao L; Li H; Tang QZ
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1143-54. PubMed ID: 25713304
[TBL] [Abstract][Full Text] [Related]
11. IcarisideII improves left ventricular remodeling in spontaneously hypertensive rats by inhibiting the ASK1-JNK/p38 signaling pathway.
Wu Y; Qian Z; Fu S; Yue Y; Li Y; Sun R; Huang B; Yang D
Eur J Pharmacol; 2018 Jan; 819():68-79. PubMed ID: 29175071
[TBL] [Abstract][Full Text] [Related]
12. Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.
Zhang Y; Liu Y; Zhu XH; Zhang XD; Jiang DS; Bian ZY; Zhang XF; Chen K; Wei X; Gao L; Zhu LH; Yang Q; Fan GC; Lau WB; Ma X; Li H
Cardiovasc Res; 2014 Apr; 102(1):35-45. PubMed ID: 24413772
[TBL] [Abstract][Full Text] [Related]
13. Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation.
Nakagawa H; Maeda S; Hikiba Y; Ohmae T; Shibata W; Yanai A; Sakamoto K; Ogura K; Noguchi T; Karin M; Ichijo H; Omata M
Gastroenterology; 2008 Oct; 135(4):1311-21. PubMed ID: 18700144
[TBL] [Abstract][Full Text] [Related]
14. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
15. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
16. Cellular FLICE-like inhibitory protein protects against cardiac hypertrophy by blocking ASK1/p38 signaling in mice.
Huang Y; Wu L; Wu J; Li Y; Hou L
Mol Cell Biochem; 2014 Dec; 397(1-2):87-95. PubMed ID: 25087120
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
18. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
[TBL] [Abstract][Full Text] [Related]
19. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA
Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
